News

Press ReleaseCell and Gene Therapy Catapult and UCL Researcher-in-Residence to develop a digital twin of CAR-T manufacturing
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Regulatory Round-up - August 2024Regulatory Round-up - August 2024Regulatory Round-up - July 2024Regulatory Round-up - July 2024Challenge Theme R&D spotlight: Identifying potential targets to monitor and control differentiation of stem cells to haematopoietic progenitor cellsChallenge Theme R&D spotlight: Identifying potential targets to monitor and control differentiation of stem cells to haematopoietic progenitor cellsPatient first: Highlights from the RSM’s “Unveiling Gene Therapy: Transforming medical practice through ATMPs” eventPatient first: Highlights from the RSM’s “Unveiling Gene Therapy: Transforming medical practice through ATMPs” eventCGT Catapult establishes consortium to improve AAV formulationCGT Catapult establishes consortium to improve AAV formulationRegulatory Round-up - June 2024Regulatory Round-up - June 2024Plurify and the Cell and Gene Therapy Catapult to develop technology that improves purity of cell therapiesPlurify and the Cell and Gene Therapy Catapult to develop technology that improves purity of cell therapiesRegulatory Round-up - May 2024Regulatory Round-up - May 2024CATTI and the Cell and Gene Therapy Catapult to establish shared training standards for advanced therapies manufacturingCATTI and the Cell and Gene Therapy Catapult to establish shared training standards for advanced therapies manufacturingCGT Catapult establishing digital and automation testbeds to enable the scale-up of advanced therapy manufacturingCGT Catapult establishing digital and automation testbeds to enable the scale-up of advanced therapy manufacturingChallenge Theme R&D spotlight: Development of an end-to-end scalable AAV platformChallenge Theme R&D spotlight: Development of an end-to-end scalable AAV platformPress ReleaseUK and Swiss consortium to apply innovative technologies to lower cost of manufacturing cell and gene therapies